Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP versus glucocorticoid versus saline for lateral epicondylitis
ACTRN12613000616774Phase 2Completed
- Sponsor
- Monash University
- Start
- Jun 2013
- Modality
- Adoptive Cell Transfer → Cell Therapies, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of autologous platelet-rich plasma, betamethasone sodium and saline in Lateral Epicondylitis (LET) (3 arms), sponsored by Monash University. Primary endpoints: Global pain assessment at 52 weeks and Patient-rated Tennis Elbow Evaluation at 52 weeks. Started Jun 2013; status: completed.
02
Drugs
autologous platelet-rich plasmabetamethasone sodiumsaline
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on ACTRN12613000616774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000616774.